home / stock / mkgaf / mkgaf short
Short Information | Merck Kgaa (OTCMKTS:MKGAF)
Twenty Trading Day Totals | |
---|---|
Total Shorted Volume | 2,310 |
Total Actual Volume | 25,162 |
Short Trends | |
---|---|
Cover Days | 4 |
Short Days | 14 |
No Change Days | 2 |
Averages | |
---|---|
Average Short Volume | 116 |
Average Short Percentage | 61.40% |
Is there a MKGAF Short Squeeze or Breakout about to happen?
See the MKGAF Short Analysis for free Sign up or Login
Powered by Squeeze Report
Date | Open | Close | High | Low | Total Volume | Short Volume | Short Percentage |
---|---|---|---|---|---|---|---|
05-03-2024 | $165.973 | $162.23 | $165.973 | $161.816 | 58 | 55 | 94.83% |
05-02-2024 | $161.436 | $162 | $163.202 | $158.407 | 223 | 146 | 65.47% |
05-01-2024 | $162.145 | $154.105 | $162.145 | $154.105 | 21 | 18 | 85.71% |
04-30-2024 | $162.285 | $161 | $162.285 | $161 | 56 | 56 | 100% |
04-29-2024 | $161.414 | $163.263 | $163.263 | $160.035 | 42 | 24 | 57.14% |
04-26-2024 | $166.52 | $157.08 | $166.52 | $157.08 | 82 | 81 | 98.78% |
04-25-2024 | $154.8 | $165.33 | $165.33 | $154.8 | 1,092 | 118 | 10.81% |
04-19-2024 | $155.985 | $156 | $156.035 | $154.315 | 361 | 351 | 97.23% |
04-17-2024 | $156.85 | $158.75 | $160.522 | $156.85 | 313 | 147 | 46.96% |
04-16-2024 | $162.381 | $162.381 | $162.381 | $162.381 | 5 | 5 | 100% |
04-15-2024 | $163.69 | $162 | $163.69 | $158.98 | 267 | 159 | 59.55% |
04-12-2024 | $163.361 | $163.51 | $163.75 | $161.777 | 285 | 163 | 57.19% |
04-11-2024 | $163.465 | $164.9 | $164.9 | $161.95 | 41 | 23 | 56.1% |
04-10-2024 | $161.6 | $161.5 | $162.627 | $160.8 | 671 | 46 | 6.86% |
04-09-2024 | $166.805 | $168.25 | $168.25 | $165.1 | 113 | 45 | 39.82% |
04-08-2024 | $166.63 | $162.616 | $166.63 | $162.616 | 29 | 23 | 79.31% |
04-05-2024 | $167.53 | $162 | $167.9 | $160.57 | 205 | 145 | 70.73% |
04-04-2024 | $170.6 | $169.1 | $170.6 | $169.1 | 566 | 11 | 1.94% |
04-03-2024 | $169.41 | $171.5 | $173.192 | $169.41 | 20,068 | 34 | 0.17% |
04-01-2024 | $180.43 | $176.5 | $180.43 | $172.935 | 664 | 660 | 99.4% |
News, Short Squeeze, Breakout and More Instantly...
Gevo Inc. (GEVO) is expected to report $-0.05 for Q4 2023 Harvard Bioscience Inc. (HBIO) is expected to report $0.03 for Q4 2023 QuantaSing Group Limited (QSG) is expected to report $0.11 for Q2 2024 DFI Retail Group Holdings Limited ADR (DFIHY) is expected to report for quarter end 2...
Merck KGaA (OTC: MKGAF) (OTC: MKKGY) says its two Phase 3 EVOLUTION trials (evolutionRMS 1 and evolutionRMS 2) of evobruti...
Evotec SE (EVO) is expected to report $-0.03 for Q3 2023 Amplifon (AMFPF) is expected to report for Q3 2023 Compass Therapeutics Inc. (CMPX) is expected to report $-0.11 for Q3 2023 Astronics Corp. - Class B (ATROB) is expected to report for Q4 2023 Charge Enterprises Inc. (CRGE) ...